Clinical trial Recruiting at 2 sites Phase 4 Interventional Ages 18 to 65 Women only

Infusion of pain relief medication after minimally invasive hysterectomy

Official title: The Impact of the Continuous Infusion of Intraperitoneal Analgesics on Postoperative Pain After Minimally Invasive Hysterectomy: a Randomized Controlled Trial

Run by George Washington University · NCT04130464 · Data updated 2026-11-12

This study is testing if a continuous infusion of pain relief medication can help women feel less pain after having a minimally invasive hysterectomy compared to a placebo.

More Pain, Postoperative trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 65 Years
SexWomen only
Enrollment120 (estimated)
SponsorGeorge Washington University
Academic / other
Locations2 sites (Washington D.C., District of Columbia and 1 other locations)
StatusRecruiting
StartedSeptember 30, 2019
Main results expectedSeptember 2026
Study endsDecember 2026
Registry record updatedApril 9, 2026
Trial IDNCT04130464 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women scheduled for a minimally invasive hysterectomy for benign gynecologic conditions.

Probably not a fit

Patients with concerns for malignancy or allergies to study medications will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of continuous intraperitoneal infusion of local anesthetic and NSAID for managing postoperative pain in women undergoing minimally invasive hysterectomy. Participants will be randomly assigned to receive either a local anesthetic, a combination of local anesthetic and NSAID, or a placebo. The study aims to determine if these interventions can significantly reduce pain and the need for narcotics post-surgery compared to a control group receiving saline. The trial will involve multiple centers and will utilize a double-blinded, placebo-controlled design to ensure unbiased results.

Why it matters

Potential benefit: If successful, this approach could significantly reduce postoperative pain and narcotic use, improving recovery for patients.

How similar studies have gone: Other studies have shown promising results with similar approaches to postoperative pain management, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Hysterectomy planned for a benign gynecologic reason (no evidence of, or concern for, malignancy in the cervix, uterus, tubes or ovaries. Benign gynecologic reasons to have a hysterectomy include fibroids, abnormal uterine bleeding, endometriosis, and pelvic pain.)
* Patient is scheduled to have surgery with a fellowship trained minimally invasive gynecologic surgeons at one of the study sites.
* Patient is planned for a robotic assisted total laparoscopic hysterectomy (RA-TLH) or a total laparoscopic hysterectomy (TLH).
* Patient is capable of informed consent.
* Patient is capable of completing the questionnaires.

Exclusion Criteria:

* Concern for malignancy
* The procedure is scheduled outside MIGS department.
* Allergy to any study related medication (i.e. Ketorolac and Ropivacaine)
* Patient is enrolled in another pain management study.

Where it's running

  • MedStar Washington Hospital Center
    Washington D.C., District of Columbia, United States
    Recruiting
  • The GW Medical Faculty Associates
    Washington D.C., District of Columbia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.